Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico

Transfusion

Volumn 49, Issue 10, 2009, Pages 2200-2207

  Calderón, Gloria M ^a   González Velázquez, Felipe ^a   González Bonilla, Cesar R ^a   Novelo Garza, Bárbara ^a   Terrazas, Jose J ^a   Martínez Rodríguez, Maria L ^a   Cortés Márquez, Silvia R ^a   Blanco Flores, Juan P ^a   Rodríguez Rodríguez, Arturo ^a   Del Campo, Maria A ^a   Cortés Gómez, Rudy ^a   Mejía Bocanegra, M Guadalupe ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTORY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEXICO; POPULATION; RECIPIENT; RISK FACTOR; SCREENING; SEROLOGY; SEROPREVALENCE; TRANSPLANTATION;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MEXICO; RISK FACTORS; YOUNG ADULT;

EID: 70350443041     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02248.x     Document Type: Article

References (39)

1. MMWR from the Centers for Disease Control and Prevention. Blood safety monitoring among persons withbleeding disorders. United States, May 1998-June 2002. JAMA 2003 289 : 541 3.
2. Allain JP. Transfusion risks of yesterday and of today. Transfus Clin Biol 2003 10 : 1 5.
3. Ocak S, Kaya H, Cetin M, Gali E, Ozturk M. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res 2006 37 : 895 8.
4. Yee TT, Lee CA. Transfusion-transmitted infection in hemophilia in developing countries. Semin Thromb Hemost 2005 31 : 527 37. Review.
5. Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients. J Trop Pediatr 2001 47 : 239 42.
6. Covas DT, Boturao Neto E, Zago MA. The frequency of blood-born viral infections in a population of poly-transfused Brazilian patients. Rev Inst Med Trop Sao Paulo 1993 35 : 271 3.
7. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis 1998 4 : 5 11.
8. Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005 18 : 12 29. Review.
9. Stainsby D, Russell J, Cohen H, Lilleyman J. Reducing adverse events in blood transfusion. Br J Haematol 2005 131 : 8 12.
10. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003 289 : 959 62.
11. Corash L. Pathogen reduction technology: methods, status of clinical trials, and future prospects. Curr Hematol Rep 2003 2 : 495 502.
12. Dhingra N, Hafner V. Safety of blood transfusion at the international level. The role of WHO. Transfus Clin Biol 2006 13 : 200 2.
13. Norma Oficial Mexicana NOM-003-SSA2-1993 para la disposición de sangre humana y sus componentes con fines terapeúticos. México : Diario Oficial de la Federación 1993.
14. Modificación a la norma Oficial Mexicana NOM-010-SSA2-1993, para la Prevención y Control de la Infección por Virus de la Inmunodeficiencia Humana. México : Diario Oficial de la Federación 1993.
15. Valdespino-Gómez JL, García-García ML, del Río-Zolezzi A, Loo-Méndez E, Magis-Rodríguez C, Salcedo-Alvarez RA. The epidemiology of AIDS/HIV in Mexico: from 1983 to March 1995. Salud Publica Mex 1995 37 : 556 71.
16. Minichiello SN, Magis C, Uribe P, Anaya L, Bertozzi S. The Mexican HIV/AIDS surveillance system: 1986-2001. AIDS 2002 16 Suppl 3 : S13 7.
17. Volkow P, Mohar A, Terrazas JJ, Perez-Padilla JR, Vilar-Compte D, Carranza D, Sierra-Madero J. Changing risk factors for HIV infection. Arch Med Res 2002 33 : 61 6.
18. Volkow P, Velasco SR, Mueller N, Ponce de Leon S, Sierra-Madero JG, Sada E, Soto JL, Perez-Ancona F, Ruiz-Palacios G, Castillo JR, Mohar A. Transfusion-associated HIV infection in Mexico related to paid blood donors; HIV epidemic. Int J STD AIDS 2004 15 : 337 42.
19. Gonzalez-Michaca L, Mercado A, Gamba G. Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence. G Rev Invest Clin 2000 52 : 246 54.
20. Mendez-Sanchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol 2004 42 : 4321 2.
21. Rivera-Lopez MR, Zavala-Mendez C, Arenas-Esqueda A. Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors. Gac Med Mex 2004 140 : 657 60.
22. Remesar M, Gamba C, Kuperman S, Marcosa MA, Miguez G, Caldarola S, Pérez-Bianco R, Manterola A, Del Pozo A. Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina. J Clin Virol 2005 34 Suppl 2 : S20 6.
23. de Paula EV, Gonçales NS, Xueref S, Addas-Carvalho M, Gilli SC, Angerami RN, Veríssimo MP, Gonçales FL Jr. Transfusion-transmitted infections among multi-transfused patients in Brazil. J Clin Virol 2005 34 Suppl 2 : S27 32.
24. Jubelirer SJ, Arden D, Jones JW. The prevalence of viral hepatitis and HIV infections in patients with congenital bleeding disorders. W V Med J 2005 101 : 256 7.
25. López-Alcorocho JM, Barril G, Ortiz-Movilla N, Traver JA, Bartolomé J, Sanz P, Selgas R, Carreño V. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. J Med Virol 2001 63 : 103 7.
26. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd., Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002 100 : 1584 9.
27. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, Kleinman SH, Matijas L, Thomson RA, Nemo GJ. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996 275 : 995 1000.
28. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000 31 : 756 62.
29. Bialek SR, Terrault NA The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006 10 : 697 715.
30. Ramírez-Mayans J, Cervantes-Bustamante R, Zárate- Mondragón F, Mata-Rivera N, Tello M, Navarrete N, Sosa C. Hepatitis C virus antibodies in a Mexican population. Pediatr Infect Dis J 1998 17 : 169 70.
31. Martinez-Murillo C, Quintana S, Ambriz R, Benitez H, Berges A, Collazo J, Esparza A, Pompa T, Taboada C, Zavala S, Larochelle MR, Bentkover JD. Comite Mexicano de hemostasia y trombosis, economic model of hemophilia in Mexico research team. An economic model of haemophilia in Mexico. Haemophilia 2004 10 : 9 17.
32. Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data. Transplant Proc 2008 40 : 909 14.
33. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002 51 : 429 33.
34. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol 2005 23 : 41 3.
35. Kondili LA, Genovese D, Argentini C, Chionne P, Toscani P, Fabro R, Cocconi R, Rapicetta M. Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center. Eur J Clin Microbiol Infect Dis 2006 25 : 527 31.
36. Silini E, Locasciulli A, Santoleri L, Gargantini L, Pinzello G, Montillo M, Foti L, Lisa A, Orfeo N, Magliano E, Nosari A, Morra E. Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 2002 87 : 1200 8.
37. Alter MJ, Kuhnert WL, Finelli L, Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 52 (RR 1 13, 15 quiz CE1-4.
38. Contreras AM, Tornero-Romo CM, Toribio JG, Celis A, Orozco- Hernández A, Rivera PK, Méndez C, Hernández-Lugo MI, Olivares L, Alvarado MA. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion 2008 48 : 2540 8.
39. Vazquez-Flores JA, Valiente-Banuet L, Marin y Lopez RA, Sanchez-Guerrero SA. Safety of the blood supply in Mexico from 1999 to 2003. Rev Invest Clin 2006 58 : 101 8.